Cordasco Financial Network’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $227K | Buy |
4,167
+598
| +17% | +$33K | 0.16% | 81 |
|
|
2022
Q1 | $194K | Hold |
3,569
| – | – | 0.13% | 92 |
|
|
2021
Q4 | $197K | Hold |
3,569
| – | – | 0.12% | 95 |
|
|
2021
Q3 | $170K | Hold |
3,569
| – | – | 0.12% | 93 |
|
|
2021
Q2 | $178K | Hold |
3,569
| – | – | 0.12% | 91 |
|
|
2021
Q1 | $159K | Buy |
3,569
+397
| +13% | +$18K | 0.12% | 95 |
|
|
2020
Q4 | $146K | Sell |
3,172
-288
| -8% | -$13.2K | 0.12% | 92 |
|
|
2020
Q3 | $163K | Hold |
3,460
| – | – | 0.14% | 81 |
|
|
2020
Q2 | $176K | Buy |
3,460
+70
| +2% | +$3.59K | 0.16% | 77 |
|
|
2020
Q1 | $161K | Sell |
3,390
-70
| -2% | -$3.73K | 0.18% | 67 |
|
|
2019
Q4 | $203K | Buy |
3,460
+700
| +25% | +$38.9K | 0.18% | 65 |
|
|
2019
Q3 | $147K | Sell |
2,760
-341
| -11% | -$17.5K | 0.14% | 71 |
|
|
2019
Q2 | $155K | Buy |
3,101
+259
| +9% | +$13K | 0.15% | 66 |
|
|
2019
Q1 | $148K | Sell |
2,842
-718
| -20% | -$35.9K | 0.15% | 69 |
|
|
2018
Q4 | $170K | Hold |
3,560
| – | – | 0.19% | 63 |
|
|
2018
Q3 | $179K | Hold |
3,560
| – | – | 0.17% | 69 |
|
|
2018
Q2 | $179K | Sell |
3,560
-102
| -3% | -$5.14K | 0.18% | 71 |
|
|
2018
Q1 | $179K | Hold |
3,662
| – | – | 0.19% | 67 |
|
|
2017
Q4 | $162K | Sell |
3,662
-588
| -14% | -$27.2K | 0.17% | 74 |
|
|
2017
Q3 | $216K | Hold |
4,250
| – | – | 0.24% | 59 |
|
|
2017
Q2 | $229K | Hold |
4,250
| – | – | 0.26% | 53 |
|
|
2017
Q1 | $224K | Sell |
4,250
-144
| -3% | -$7.3K | 0.26% | 50 |
|
|
2016
Q4 | $212K | Sell |
4,394
-4,732
| -52% | -$234K | 0.24% | 54 |
|
|
2016
Q3 | $494K | Hold |
9,126
| – | – | 0.57% | 35 |
|
|
2016
Q2 | $494K | Sell |
9,126
-3,436
| -27% | -$181K | 0.57% | 35 |
|
|
2016
Q1 | $637K | Sell |
12,562
-9,507
| -43% | -$474K | 0.71% | 28 |
|
|
2015
Q4 | $1.11M | Sell |
22,069
-12,531
| -36% | -$639K | 0.99% | 25 |
|
|
2015
Q3 | $1.66M | Sell |
34,600
-3,012
| -8% | -$157K | 1.38% | 17 |
|
|
2015
Q2 | $1.96M | Sell |
37,612
-1,128
| -3% | -$63.5K | 1.54% | 14 |
|
|
2015
Q1 | $2.23M | Buy |
38,740
+35,604
| +1,135% | +$2.04M | 1.59% | 16 |
|
|
2014
Q4 | $168K | Buy |
3,136
+400
| +15% | +$22.4K | 0.13% | 99 |
|
|
2014
Q3 | $157K | Hold |
2,736
| – | – | 0.12% | 103 |
|
|
2014
Q2 | $183K | Hold |
2,736
| – | – | 0.14% | 91 |
|
|
2014
Q1 | $183K | Buy |
2,736
+1,360
| +99% | +$91.9K | 0.15% | 89 |
|
|
2013
Q4 | $92K | Buy |
+1,376
| New | +$89.2K | 0.07% | 113 |
|
Other funds holding GSK
JEST
Cordasco Financial Network's GSK Position: Q2 2022 in Review
Cordasco Financial Network increased its GSK (GSK) stake by 17% in Q2 2022, buying an estimated $33K and bringing the position to 4,167 shares worth $227K. The position accounts for 0.16% of the portfolio, ranked #81.
Cordasco Financial Network first reported a position in GSK in Q4 2013 and has held it in 35 quarters since. The position peaked at $2.23M in Q1 2015. 901 funds tracked by Wall St. Rank hold GSK as of Q2 2022.
- Cordasco Financial Network held 4,167 shares of GSK worth $227K as of Q2 2022.
- Cordasco Financial Network bought 598 GSK shares in Q2 2022, an estimated $33K.
- GSK made up 0.16% of Cordasco Financial Network's portfolio in Q2 2022, its #81 holding.
- Cordasco Financial Network first reported a position in GSK in Q4 2013 and has held it in 35 quarters since.
- Cordasco Financial Network's GSK position peaked at $2.23M in Q1 2015.
- 901 funds tracked by Wall St. Rank held GSK as of Q2 2022.
Based on Cordasco Financial Network's 13F filing for Q2 2022, filed 15 Jul 2022.